For the quarter ending 2026-03-31, WST had -$269,900K decrease in cash & cash equivalents over the period. $47,200K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 138,800 | 132,100 | 140,000 | 131,800 |
| Depreciation | 44,600 | 46,400 | 42,300 | 40,800 |
| Amortization | 600 | 600 | 700 | 600 |
| Stock-based compensation | 6,600 | 6,700 | 8,400 | 7,400 |
| Non-cash restructuring charges | 900 | 5,400 | - | - |
| Pension settlement charges | - | 0 | - | - |
| Non-cash restructuring charges | - | - | 900 | 800 |
| Loss on disposal of plant | - | 0 | - | - |
| Asset impairments | 300 | 7,300 | 300 | 3,800 |
| Deferred income taxes | - | -13,700 | - | - |
| Pension and other retirement plans, net | - | 600 | - | - |
| Equity in undistributed earnings of affiliates, net of dividends | - | 10,500 | - | - |
| Other non-cash items, net | -1,000 | 3,000 | -2,500 | 4,000 |
| Decrease (increase) in accounts receivable | - | -6,900 | - | - |
| (increase) decrease in inventories | - | 62,800 | - | - |
| Decrease (increase) in other current assets | - | -9,700 | - | - |
| Increase in accounts payable | - | 17,900 | - | - |
| Changes in other assets and liabilities | - | -108,100 | - | - |
| Changes in assets and liabilities | 80,300 | - | -2,000 | 24,600 |
| Net cash provided by operating activities | 89,900 | 251,100 | 197,200 | 177,100 |
| Capital expenditures | 42,700 | 76,100 | 63,300 | 75,200 |
| Other, net | - | 0 | 0 | 0 |
| Net cash used in investing activities | -42,700 | -76,100 | -63,300 | -75,200 |
| Borrowings of long-term debt | - | 0 | 0 | 0 |
| Repayments of long-term debt | - | 0 | 0 | 0 |
| Principal repayments on finance leases | 300 | 300 | 300 | 300 |
| Excise tax payments | - | 0 | 0 | 4,200 |
| Dividend payments | 15,800 | 15,800 | 15,100 | 15,100 |
| Proceeds from stock-based compensation awards | 5,500 | 3,100 | 2,200 | 3,500 |
| Employee stock purchase plan contributions | 2,000 | 1,500 | 1,800 | 1,700 |
| Shares purchased under share repurchase programs | 297,600 | 0 | 0 | 500 |
| Shares repurchased for employee tax withholdings | 2,500 | 200 | 100 | 0 |
| Net cash used in financing activities | -308,700 | -11,700 | -11,500 | -14,900 |
| Effect of exchange rates on cash | -8,400 | -500 | -3,600 | 18,500 |
| Net decrease in cash and cash equivalents | -269,900 | 162,800 | 118,800 | 105,500 |
| Cash, including cash equivalents at beginning of period | 791,300 | 628,500 | 509,700 | 404,200 |
| Cash, including cash equivalents at end of period | 521,400 | 791,300 | 628,500 | 509,700 |
WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST)